Professor of Genomics, The Scripps Research Institute, La Jolla, CA. Director of the Scripps Translational Science Institute. Elected, Institute of Medicine, National Academy of Science, 2004. Voted Most Influential Physician Executive in the US in 2012, Modern Healthcare. Thomson Reuters ISI "Doctor of the Decade" for top 10 in medicine citations. University of Michigan endowed Topol Professor of Cardiovascular Medicine, 2011.
Professor of Vascular Inflammation and Director of Graduate Studies at the William Harvey Research Institute, Barts and the London School of Medicine & Dentistry. Fellow of the American Heart Association. Fellow of the British Pharmacological Society. Fellow of the Society of Biology.
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine. Dr. Wu received his MD from Yale University School of Medicine. He trained in internal medicine and cardiology at UCLA followed by a PhD in the Dept of Molecular Pharmacology. His clinical interests involve cardiovascular imaging and adult congenital heart disease. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic cardiovascular disease mechanisms, (ii) accelerate drug discovery and screening, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision cardiovascular medicine for prevention and treatment of patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathophysiological processes.
Associate Professor at Rutgers-New Jersey Medical School, Editor of American Journal of Medical and Biological Research, Dataset Papers in Biology, Frontiers in Physiology, Journal of Cardiovascular Disease Research, PLOS One, World Journal Of Hypertension, and World Journal of Cardiology.
Researcher at Bloodworks Research Institute and UW Medicine, University of Washington. Current work mainly focuses on zwitterionic-based surface coatings for long-term biomedical applications.
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 5,951 (April 26, 2017).
Professor in Second Hospital of Jilin University.
Research Keywords: Cancer research, Stem Cell, Biochemistry, Bioenergetics, Biology and life sciences, Biotechnology, Breast tumors, Cancer, Clinical research, Complementary and alternative medicine, Cytochemistry, Cytometry, Pharmacology, Neuropharmacology, Gastrointestinal tumors, Immunochemistry, Leukemias, Lung cancer